|
| 成都地区11家医院2011～2013年口服降糖药利用分析 |
| Utilization of Oral Hypoglycemic Drugs in Eleven Hospitals of Chengdu During 2011-2013 |
| |
| DOI： |
| 中文关键词: 降糖药；口服；成都 用药频度；药物利用 |
| 英文关键词:Hypoglycemic drugs Oral Chengdu area Frequency of durg use Drug utilization |
| 基金项目: |
|
| 摘要点击次数: 801 |
| 全文下载次数: 992 |
| 中文摘要: |
| 摘 要 目的:了解成都地区口服降糖药的临床应用情况。方法：采用《医院处方分析》课题中成都地区11家医院2011～2013年口服降糖药的处方数据进行分析。结果：成都地区口服降糖药销售金额呈逐年上升趋势，双胍类一直居3年的榜首，单品种药物方面，2013年瑞格列奈销售金额上升为第1位，其次为阿卡波糖、格列美脲；格列美脲、二甲双胍各年用药频度（DDDs）中均居前3位；二甲双胍DDDs排序呈逐年下降趋势。结论：成都地区11家医院口服降糖药用量呈逐渐上升趋势，其选用药物的经济性较为合理。 |
| 英文摘要: |
| ABSTRACT Objective: To investigate the utilization of oral hypoglycemic drugs in Chengdu area．Methods: The utilization of oral hypoglycemic drugs in 11 hospitals of Chengdu area from 2011 to 2013 were analyzed statistically. Results:There was an upward trend in the consumption sum for the oral medications in Chengdu area, and biguanides took up the first place in the list of consumption sum in 3 years. The top one oral hypoglycemic drug in the list of consumption sum was repaglinide in 2013, followed by acarbose, glimepiride. In terms of DDDs, glimepiride and metformin ranked the top 3 during the 3 years. The rank DDDs of metformin was decreased year by year. Conclusion:The demanded quantity of oral hypoglycemic drugs was increased year by year from 2011 to 2013. The utilization of oral hypoglycemic drugs in Chengdu area was economical. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
